Canvax
Canvax Biotech, founded in 2001 and based in Spain, is a biotechnology company developing and manufacturing a broad portfolio of molecular and cell biology reagents. With interconnected business divisions spanning reagents, drug discovery, and biosensors, Canvax combines innovation with high-quality manufacturing to support both basic research and applied science.
Its primary focus lies in R&D reagents and tools, where Canvax is a major manufacturer of laboratory essentials. The catalogue includes PCR and qPCR products such as polymerases and Master Mixes (e.g., qMAXSen™), DNA/RNA extraction kits from diverse samples, and cloning kits. In cell biology, the range covers reagents for cell culture, transfection, and assays for apoptosis, proliferation, and reporter genes. Canvax also provides custom and bulk manufacturing of enzymes, buffers, and recombinant proteins, with production capacities from grams to kilograms under cGMP standards.
Beyond reagents, Canvax advances drug discovery with a focus on cancer, psoriasis, and Parkinson’s disease, supported by expertise in GPCR expression for target identification. The company also pioneers biosensors with its Molecular Nose™ technology, a platform with applications in early cancer detection as well as in the fragrance and cosmetics industries.
